Anthony D. Piscopio
Founder at OnKure, Inc.
Network origin in Anthony D. Piscopio first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Subsidiary | Pharmaceuticals: Major | 18 | |
OnKure, Inc.
 OnKure, Inc. BiotechnologyHealth Technology OnKure, Inc. engages in the discovery and development of epigenetic therapies for the treatment of cancer. It develops selective inhibitors of histone deacetylases in preclinical models of both hematological and solid tumor cancers. The company was founded by Xuedong Liu and Anthony D. Piscopio in April 2011 and is headquartered in Longmont, CO.
7
| Holding Company | Biotechnology | 7 |
Core Brewing & Distilling Co. LLC
 Core Brewing & Distilling Co. LLC Beverages: AlcoholicConsumer Non-Durables Core Brewing & Distilling Co. LLC engages in the brewing of beer. It offers year-round, limited-release, and taproom beers. The company was founded by Jesse Core in September 2010 and is headquartered in Springdale, AK.
6
| Private Company | Beverages: Alcoholic | 6 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Anthony D. Piscopio via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| The University of Colorado | College/University | Corporate Officer/Principal Doctorate Degree Masters Business Admin Corporate Officer/Principal Masters Business Admin | |
| AMGEN INC. | Pharmaceuticals: Major | Founder Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal | |
| ARCA BIOPHARMA, INC. | Pharmaceuticals: Major | Director/Board Member Chairman Corporate Officer/Principal Director/Board Member | |
| Colorado State University | College/University | Undergraduate Degree Doctorate Degree Undergraduate Degree | |
BaroFold, Inc.
 BaroFold, Inc. Pharmaceuticals: MajorHealth Technology BaroFold, Inc. develops and commercializes protein therapeutics. Its services include protein refolding, protein analytical and aggregate characterization, formulation stability and immunogenicity studies, and microbial expression. The company was founded by Matthew Seefeldt, Matthew Brewer, John F. Carpenter, Ted Randolph, Timothy C. Rodell, and Lyndal K. Hesterberg in 2009 and is headquartered in Aurora, CO. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chairman | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| PELOTON THERAPEUTICS, INC. | Pharmaceuticals: Major | General Counsel Chief Executive Officer Chief Tech/Sci/R&D Officer | |
| EDGEWISE THERAPEUTICS, INC. | Biotechnology | General Counsel Chief Executive Officer Director of Finance/CFO | |
| Rochester Christian University | College/University | Doctorate Degree Doctorate Degree | |
| ELEVATION ONCOLOGY, INC. | Biotechnology | Director/Board Member Director/Board Member | |
Boulder Ventures Ltd.
 Boulder Ventures Ltd. Investment ManagersFinance Boulder Ventures Ltd (Boulder Ventures) is a venture capital firm founded in 1995 by Kyle Lefkoff. The firm is headquartered in Boulder, Colorado with an additional office in Chevy Chase, Maryland. | Investment Managers | Private Equity Investor Founder | |
ArcherDX LLC
 ArcherDX LLC Packaged SoftwareTechnology Services ArcherDX LLC is a genomic analysis company, which develops software solutions for investigating cancer treatment. Its products include VariantPlex, FusionPlex, LiquidPlex, reveal ctDNA, Immunoverse, custom assays, and archer analysis. The company was founded by Jason W. Myers, A. John Iafrate, and Long Phi Le on January 1, 2013 and is headquartered in Boulder, CO. | Packaged Software | Director/Board Member Director/Board Member | |
| The University of Chicago | College/University | Masters Business Admin Masters Business Admin | |
Puretech Health LLC
 Puretech Health LLC Investment ManagersFinance Puretech Health LLC (PureTech Ventures) is a venture capital subsidiary of PureTech Health Plc founded in 2000 by Daphne Zohar, Robert Langer and Ben Shapiro. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Founder Corporate Officer/Principal | |
| BIOGEN INC. | Pharmaceuticals: Major | President Chief Tech/Sci/R&D Officer | |
| VIRIDIAN THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| ALPINE IMMUNE SCIENCES, INC. | Biotechnology | Director/Board Member Director of Finance/CFO | |
ClinOne, Inc.
 ClinOne, Inc. Packaged SoftwareTechnology Services ClinOne, Inc. develops mobile software application. The firm serves for sites and patients. It offers elaerning, screening, documents, videos, econsent, procedure manager, and adverse events services. The company was founded by Rob Bohacs and Eric Schraufnagel and is headquartered in Denver, CO. | Packaged Software | Chairman Director of Finance/CFO | |
Genstar Capital Management LLC
 Genstar Capital Management LLC Investment ManagersFinance Genstar Capital Management LLC is a private equity firm founded in 1988 by Dennis H. Chookaszian. The firm is headquartered in San Francisco., California. | Investment Managers | Investment Committee Member Consultant / Advisor | |
Immunex Corp.
 Immunex Corp. BiotechnologyHealth Technology Immunex Corporation is a leading biopharmaceutical company dedicated to improving lives through immune system science innovation | Biotechnology | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| COGENT BIOSCIENCES, INC. | Biotechnology | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
| AC IMMUNE SA | Pharmaceuticals: Major | Chairman | |
Anadys Pharmaceuticals, Inc.
 Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Anadys Pharmaceuticals, Inc. develops and manufactures novel small molecule medicines. It engages in developing novel medicines in the areas of hepatitis C and oncology. The firm develops ANA598, a direct-acting antiviral for the treatment of hepatitis C. The company was founded by Stelios B. Papadopoulos and Kleanthis G. Xanthopoulos in 1992 and is headquartered in Little Falls, NJ. | Pharmaceuticals: Major | Director/Board Member | |
| Massachusetts Institute of Technology | College/University | Doctorate Degree | |
Genesis Research & Development Corp. Ltd.
 Genesis Research & Development Corp. Ltd. Financial ConglomeratesFinance Genesis Research & Development Corp. Ltd. operates as a development stage company. Previously, it was a technology investment company that builds a broad therapeutic development platform targeting immune disorders and cancer and a novel single stranded gene silencing technology using the RNAi mechanism. The company was founded by James Douglas Watson in 1994 and is headquartered in Auckland, New Zealand. | Financial Conglomerates | Corporate Officer/Principal | |
| Minnesota State University Moorhead | College/University | Undergraduate Degree | |
True North Therapeutics, Inc.
 True North Therapeutics, Inc. BiotechnologyHealth Technology True North Therapeutics, Inc. operates as a biopharmaceutical company. It focuses on the discovery, development, and commercialization of first-in-class product candidates for complement-mediated diseases. The company was founded by Nancy E. Stagliano in 2013 and is headquartered in South San Francisco, CA. | Biotechnology | Director/Board Member | |
ReViral Ltd.
 ReViral Ltd. BiotechnologyHealth Technology ReViral Ltd. specializes in the areas of virology and antiviral therapies. It offers drugs to treat respiratory synctial virus infection. The company was founded by Neil Matthews and Stuart Cockerill in 2011 and is headquartered in Stevenage, the United Kingdom. | Biotechnology | Director/Board Member | |
| ADDEX THERAPEUTICS LTD | Pharmaceuticals: Major | Director/Board Member | |
Fred Hutchinson Cancer Research Center
 Fred Hutchinson Cancer Research Center Miscellaneous Commercial ServicesCommercial Services Fred Hutchinson Cancer Research Center is a non-profit organization which provides research and testing services. The company was founded in 1965 and is headquartered in Seattle, WA. | Miscellaneous Commercial Services | Director/Board Member | |
| State University of New York at Buffalo | College/University | Doctorate Degree | |
Renovacor Holdings, Inc.
 Renovacor Holdings, Inc. BiotechnologyHealth Technology Renovacor, Inc. operates as a preclinical stage biopharmaceutical company focused on developing transformative gene therapy based treatments for cardiovascular disease. The company is headquartered in Philadelphia, PA. | Biotechnology | Director/Board Member | |
Acorn Capital Advisors LLC
 Acorn Capital Advisors LLC Investment ManagersFinance Acorn Capital Advisors LLC (Acorn Bioventures) is a venture capital firm founded in the year 2017. The firm is headquartered in New York. | Investment Managers | Private Equity Investor | |
Schering-Plough Research Institute
 Schering-Plough Research Institute Medical SpecialtiesHealth Technology Schering-Plough Research Institute provides pharmaceutical research. The company is headquartered in Kenilworth, NJ. | Medical Specialties | Chief Tech/Sci/R&D Officer | |
| Atherex Corp. | Director/Board Member | ||
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Doctorate Degree | |
Health Advances LLC
 Health Advances LLC Pharmaceuticals: MajorHealth Technology Health Advances LLC provides consulting services to the health care industry. It offers clinical development strategy, lifecycle management, partnering and licensing, portfolio planning, product positioning, strategic and business planning, technology commercialization, valuation and financial analysis. The company was founded by Paula Ness Sprees and Mark S. Sprees in 1992 and is headquartered in Weston, MA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| CODIAK BIOSCIENCES | Pharmaceuticals: Major | Chief Executive Officer | |
| The University of Texas at Austin | College/University | Doctorate Degree | |
| University of Massachusetts Lowell | College/University | Undergraduate Degree | |
Cygnal Therapeutics, Inc.
 Cygnal Therapeutics, Inc. BiotechnologyHealth Technology Cygnal Therapeutics, Inc. develops drugs for cancer, immunological diseases and regenerative processes. The company was founded by Noubar Afeyan, Avak Kahvejian and Jordi Mata-Fink in 2017 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
Xenikos BV
 Xenikos BV Medical SpecialtiesHealth Technology Xenikos BV focuses on the development of immunotherapies for the treatment of patients suffering from immune diseases. It is developing a combination of two toxin-loaded anti-T-cell antibodies, T-Guard, as a therapeutic tool for resetting the body's immune system in T-cell mediated diseases. The company was founded by Ypek van Oosterhout in September 2009 and is headquartered in Nijmegen, the Netherlands. | Medical Specialties | Chairman |
Statistics
International
| United States | 45 |
| Switzerland | 3 |
| New Zealand | 2 |
| United Kingdom | 2 |
| Netherlands | 2 |
Sectoral
| Health Technology | 30 |
| Consumer Services | 10 |
| Finance | 8 |
| Technology Services | 3 |
| Commercial Services | 2 |
Operational
| Director/Board Member | 139 |
| Corporate Officer/Principal | 52 |
| Independent Dir/Board Member | 28 |
| Undergraduate Degree | 21 |
| President | 19 |
Most connected contacts
| Insiders | |
|---|---|
| Douglas Williams | 25 |
| Andrew Phillips | 23 |
| John L. Zabriskie | 22 |
| Robert Conway | 21 |
| Kyle A. Lefkoff | 21 |
| Robert W. Overell | 16 |
| Kevin Koch | 15 |
| R. Carruthers | 15 |
| Isaac Manke | 15 |
| John Josey | 13 |
| Marvin H. Caruthers | 13 |
| John Moore | 12 |
| Nicholas A. Saccomano | 10 |
| Eli M. Wallace | 9 |
| Gil van Lunsen | 9 |
- Stock Market
- Insiders
- Anthony D. Piscopio
- Company connections
